SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-21-031881
Filing Date
2021-02-08
Accepted
2021-02-08 11:06:30
Documents
9

Document Format Files

Seq Description Document Type Size
1 424B4 d19221d424b4.htm 424B4 2439174
2 GRAPHIC g19221g03j18.jpg GRAPHIC 181634
3 GRAPHIC g19221g11s50.jpg GRAPHIC 56701
4 GRAPHIC g19221g13x74.jpg GRAPHIC 185168
5 GRAPHIC g19221g22z86.jpg GRAPHIC 222649
6 GRAPHIC g19221g45g64.jpg GRAPHIC 128212
7 GRAPHIC g19221g59v26.jpg GRAPHIC 60038
8 GRAPHIC g19221g72g91.jpg GRAPHIC 71705
9 GRAPHIC g19221g82y33.jpg GRAPHIC 70371
  Complete submission text file 0001193125-21-031881.txt   3765716
Mailing Address 1412 62ND STREET EMERYVILLE CA 94608
Business Address 1412 62ND STREET EMERYVILLE CA 94608 (814) 574-1546
Lucira Health, Inc. (Filer) CIK: 0001652724 (see all company filings)

IRS No.: 272491037 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-252164 | Film No.: 21600011
SIC: 2835 In Vitro & In Vivo Diagnostic Substances